Wild Berry Boosts Effects of Chemotherapy in Pancreatic Cancer

Share this content:
Chokeberry extract enhances cytotoxicity of gemcitabine on a single cancer cell line.
Chokeberry extract enhances cytotoxicity of gemcitabine on a single cancer cell line.

The use of micronutrients may augment the cytotoxic effects of chemotherapy drugs on cancer cells, according to research published in the Journal of Clinical Pathology.

Noor Azela Abdullah Thani, of Middlesex University in London, and colleagues used assays to assess the effects of gemcitabine, alone or in combination with chokeberry extract, on the growth of AsPC-1, an established human pancreatic cell line. Pancreatic cancer was chosen as a target because of the poor prognosis despite advances in therapy.

RELATED: New Agent May Help Lower Morbidity and Improve Outcomes in Patients With Pancreatic Cancer

The researchers found that gemcitabine combined with chokeberry extract was more effective than gemcitabine alone in inhibiting the growth of the AsPC-1 cell line. Colorimetric and fluorometric methods showed that apoptosis occurred at a 1 µg/mL concentration of chokeberry.

"In conclusion, this study suggested that polyphenolics from chokeberry extract induces apoptosis in the established pancreatic cell line used," the authors write. "Furthermore, when cells were treated in combination with gemcitabine, the IC50 values decreased, indicating that the effects seen are at least supra-additive, if not synergistic."

Reference

  1. Thani, Noor Azela Abdullah, et al. "Cytotoxicity of gemcitabine enhanced by polyphenolics from Aronia melanocarpa in pancreatic cancer cell line AsPC-1." Journal of Clinical Pathology. doi:10.1136/jclinpath-2013-202075. September 17, 2014.

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs